February 26, 2009
Biotech, cancer, Drugs Luke Timmerman wrote: Off the coast of the Bahamas, in sea grass more than a half-mile deep, San Diego-based Nereus Pharmaceuticals found a fungus that may be the key ingredient for an innovative new cancer drug. This will be a key year for gathering evidence that will either ...
Xconomy
[ Feed -
Focus -
Exclude ]
by
Luke Timmerman
at 5:00 AM
| 1 Citations
February 11, 2009
Biotech, obesity, Life Sciences Luke Timmerman wrote: Fen-phen was the wonder drug for weight loss in the 1990s, until it was found to damage heart valves and yanked off the market. Now the folks at San Diego-based Arena Pharmaceuticals are eagerly waiting clinical trial results that will show wheth...
Xconomy
[ Feed -
Focus -
Exclude ]
by
Luke Timmerman
at 2:00 AM
| 2 Citations
December 12, 2008
Biotech, vaccines, Xconomy Luke Timmerman wrote: A newfound energy is coalescing around the science and business of vaccines, and much of it is happening right here in Seattle. We explored the trend yesterday evening in our first Xconomy Forum in Seattle. The event, held at The Institute for Systems...
Xconomy
[ Feed -
Focus -
Exclude ]
by
Luke Timmerman
at 12:00 PM
| 1 Citations
April 17, 2008
The European Heart Journal has published data from a two year follow up of the Rimonabant In Obesity - Europe study. A summary of the article is available via the National Electronic Library for Medicine. The original RIO-Europe study recruited 1,057 individuals with a body mass index (BMI) of 30kg/...
PharmaGossip
[ Feed -
Focus -
Exclude ]
at 5:14 AM




